SMS Pharmaceuticals Limited (NSE: SMSPHARMA) announced on May 22, 2026, that its board of directors has recommended a final dividend of ₹0.40 per equity share for the financial year ended March 31, 2026. The announcement was made alongside the declaration of the company's Q4 FY26 financial results, with the dividend subject to shareholder approval at the ensuing Annual General Meeting.

Dividend Details

The recommended final dividend of ₹0.40 per share on a face value of ₹1 per equity share translates to a dividend yield of approximately 0.10% based on the current market price of ₹395. The total dividend outflow, based on the company's market capitalisation of ₹3,699.26 Cr, would be distributed across its full equity base. The dividend is classified as a final dividend for FY26.

Comparison With Previous Year

The FY26 payout is flat year-on-year, matching the ₹0.40 per share final dividend declared on May 30, 2025, for FY25. This marks the second consecutive year at the ₹0.40 level, following a step-up from ₹0.30 per share, which was consistently paid across FY22, FY23, and FY21.

Dividend History and Trend

A review of SMS Pharmaceuticals' dividend history over nearly a decade reveals a gradual upward trajectory in payouts:

The company has maintained an unbroken dividend payment record since at least FY17, demonstrating consistent shareholder return intent. However, dividend growth has plateaued over the past two fiscal years, with no incremental increase from the ₹0.40 level established in FY25.

Market Context and Valuation

SMSPHARMA shares were trading at ₹395 on May 22, 2026, a decline of 7.24% on the day, with the stock down ₹30.85 from the previous close. The current price places the stock well below its 52-week high of ₹447.80 recorded on April 15, 2026, but significantly above its 52-week low of ₹207.70 hit on June 19, 2025, indicating a strong recovery of nearly 90% from the trough before the recent pullback.

The stock trades at a price-to-earnings ratio of 45.78x, which is exactly in line with the sector PE of 45.78x, suggesting the market is pricing SMSPHARMA at par with its pharmaceutical peers on an earnings basis.

Trading Activity and Delivery Data

On the announcement date, SMSPHARMA recorded a trading volume of 9,53,139 shares with a delivery percentage of 33.54%. A delivery percentage below 40% on a results and dividend announcement day indicates a meaningful proportion of the day's activity was driven by intraday traders rather than investors taking or building positional exposure. The daily volatility stands at 3.04%, reflecting elevated price movement risk around the results event.

Company Background

SMS Pharmaceuticals Limited is a Hyderabad-based active pharmaceutical ingredient (API) manufacturer listed on the NSE. The company reported its FY26 financial results on the same day as the dividend announcement, with the board meeting concluding on May 22, 2026. Its ISIN is INE812G01017.

The record date and payment date for the FY26 final dividend are yet to be announced and will be communicated to the exchanges in a subsequent filing pending shareholder approval.